|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 19 January 2021, 9:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 1.11MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.000% short sold according to ASIC data. It was ranked the 641st most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| FDA Grants an IND for NanaBis and Investor Webcast | 19 January 2021, 9:20 |
| Change of Director's Interest Notice | 30 December 2020, 10:38 |
| 2020 Research Program Update | 9 December 2020, 9:13 |
| NanaBis Observational Study Progression Report | 30 November 2020, 10:00 |
You must be logged in to post a reply.
Medlab Clinical 